{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:05:33Z","timestamp":1787162733867,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.bmcl.2022.128531","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T11:35:00Z","timestamp":1641555300000},"page":"128531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Modification of the benzenoid part"],"prefix":"10.1016","volume":"59","author":[{"given":"Sarah H.","family":"Megahed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebaa M.","family":"El-Hossary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahia I.","family":"El-Shabrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf H.","family":"Abadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abdel-Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bmcl.2022.128531_b0005","doi-asserted-by":"crossref","first-page":"e0189621","DOI":"10.1371\/journal.pone.0189621","article-title":"Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis","volume":"12","author":"Founou","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2022.128531_b0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jgar.2018.11.019","article-title":"Epidemiology of antimicrobial resistance in Lebanese extra-hospital settings: An overview","volume":"17","author":"Osman","year":"2019","journal-title":"J Glob Antimicrob Resist."},{"issue":"3","key":"10.1016\/j.bmcl.2022.128531_b0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol Mol Biol Rev."},{"issue":"23","key":"10.1016\/j.bmcl.2022.128531_b0020","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1002\/anie.201506818","article-title":"Targeting antibiotic resistance","volume":"55","author":"Chellat","year":"2016","journal-title":"Angew Chem Int Ed."},{"issue":"2","key":"10.1016\/j.bmcl.2022.128531_b0025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01510-17","article-title":"A novel mechanism of inactivating antibacterial nitro compounds in the human pathogen Staphylococcus aureus by Overexpression of a NADH-dependent flavin nitroreductase","volume":"62","author":"El-Hossary","year":"2018","journal-title":"Antimicrob Agents Chemother."},{"issue":"7","key":"10.1016\/j.bmcl.2022.128531_b0030","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jsps.2017.04.022","article-title":"Synthesis and anticancer activity of new quinazoline derivatives","volume":"25","author":"Abuelizz","year":"2017","journal-title":"Saudi Pharm J."},{"issue":"6","key":"10.1016\/j.bmcl.2022.128531_b0035","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.pneumo.2013.08.004","article-title":"Staphylococcus aureus broncho-pulmonary infections","volume":"69","author":"Valour","year":"2013","journal-title":"Rev Pneumol Clin"},{"issue":"8","key":"10.1016\/j.bmcl.2022.128531_b0040","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.bmcl.2022.128531_b0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev Anti Infect Ther."},{"issue":"4","key":"10.1016\/j.bmcl.2022.128531_b0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.21307\/pjm-2018-043","article-title":"Emergence of high-level gentamicin resistance among enterococci clinical isolates from burn patients in south-west of Iran: vancomycin still working","volume":"67","author":"Labibzadeh","year":"2018","journal-title":"Pol J Microbiol."},{"issue":"Supplement_3","key":"10.1016\/j.bmcl.2022.128531_b0055","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1086\/519471","article-title":"Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"45","author":"Micek","year":"2007","journal-title":"Clin Infect Dis."},{"issue":"Supplement_1","key":"10.1016\/j.bmcl.2022.128531_b0060","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/491711","article-title":"Vancomycin resistance in gram-positive cocci","volume":"42","author":"Courvalin","year":"2006","journal-title":"Clin Infect Dis."},{"issue":"9","key":"10.1016\/j.bmcl.2022.128531_b0065","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1586\/14779072.2013.832482","article-title":"Enterococcus faecalis infective endocarditis: focus on clinical aspects","volume":"11","author":"Dahl","year":"2013","journal-title":"Expert Rev Cardiovasc Ther."},{"issue":"1","key":"10.1016\/j.bmcl.2022.128531_b0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1086\/500000","article-title":"Risk factors and outcomes associated with non-Enterococcus faecalis, non-Enterococcus faecium enterococcal bacteremia","volume":"27","author":"Perio","year":"2006","journal-title":"Infect Control Hosp Epidemiol."},{"issue":"2","key":"10.1016\/j.bmcl.2022.128531_b0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diagmicrobio.2006.12.022","article-title":"Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program","volume":"58","author":"Deshpande","year":"2007","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"5","key":"10.1016\/j.bmcl.2022.128531_b0080","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1469-0691.2010.03183.x","article-title":"Streptococcus pneumoniae: virulence factors and variation","volume":"16","author":"Mitchell","year":"2010","journal-title":"Clin Microbiol Infect."},{"issue":"6","key":"10.1016\/j.bmcl.2022.128531_b0085","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1086\/319341","article-title":"Penicillin-resistant Streptococcus pneumoniae endocarditis: A case report and review","volume":"32","author":"Siegel","year":"2001","journal-title":"Clin Infect Dis."},{"issue":"3","key":"10.1016\/j.bmcl.2022.128531_b0090","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1097\/MJT.0000000000000551","article-title":"Antimicrobial resistant Streptococcus pneumoniae: prevalence, mechanisms, and clinical implications","volume":"24","author":"Cherazard","year":"2017","journal-title":"Am J Ther."},{"issue":"7","key":"10.1016\/j.bmcl.2022.128531_b0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1517\/13543776.2015.1039512","article-title":"Quinazoline derivatives as anticancer drugs: a patent review (2011 \u2013 present)","volume":"25","author":"Ravez","year":"2015","journal-title":"Expert Opin Ther Pat."},{"issue":"12","key":"10.1016\/j.bmcl.2022.128531_b0100","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1248\/bpb.26.1711","article-title":"Synthesis, analgesic, anti-inflammatory and antibacterial activities of some novel 2-methyl-3-substituted quinazolin-4-(3H)-ones","volume":"26","author":"Alagarsamy","year":"2003","journal-title":"Biol Pharm Bull."},{"issue":"10","key":"10.1016\/j.bmcl.2022.128531_b0105","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1007\/s00044-013-0468-9","article-title":"Synthesis, anti-inflammatory, and structure antioxidant activity relationship of novel 4-quinazoline","volume":"22","author":"Hussein","year":"2013","journal-title":"Med Chem Res."},{"issue":"11","key":"10.1016\/j.bmcl.2022.128531_b0110","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.ejmech.2010.07.067","article-title":"Synthesis, analgesic and anti-inflammatory evaluation of some novel quinazoline derivatives","volume":"45","author":"Alafeefy","year":"2010","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bmcl.2022.128531_b0115","first-page":"1","article-title":"Chemical characteristics, synthetic methods, and biological potential of quinazoline and quinazolinone derivatives","volume":"2014","author":"Asif","year":"2014","journal-title":"Int J Med Chem."},{"issue":"1","key":"10.1016\/j.bmcl.2022.128531_b0120","first-page":"1","article-title":"Quinazolinone and quinazoline derivatives: recent structures with potent antimicrobial and cytotoxic activities","volume":"11","author":"Jafari","year":"2016","journal-title":"Res Pharm Sci."},{"key":"10.1016\/j.bmcl.2022.128531_b0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejmech.2019.03.018","article-title":"4(3H)-Quinazolinone derivatives: Promising antibacterial drug leads","volume":"170","author":"Gatadi","year":"2019","journal-title":"Eur J Med Chem."},{"issue":"3","key":"10.1016\/j.bmcl.2022.128531_b0130","doi-asserted-by":"crossref","first-page":"e1700513","DOI":"10.1002\/cbdv.201700513","article-title":"Synthesis, cytotoxic, and antibacterial evaluation of quinazolinone derivatives with substituted amino moiety","volume":"15","author":"Zhan","year":"2018","journal-title":"Chem Biodivers."},{"issue":"19","key":"10.1016\/j.bmcl.2022.128531_b0135","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1016\/j.bmcl.2016.08.022","article-title":"Synthesis, biological evaluation and molecular modeling study of some new methoxylated 2-benzylthio-quinazoline-4(3H)-ones as nonclassical antifolates","volume":"26","author":"El-Messery","year":"2016","journal-title":"Bioorganic Med Chem Lett."},{"issue":"20","key":"10.1016\/j.bmcl.2022.128531_b0140","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1016\/j.bmcl.2004.07.065","article-title":"Synthesis and biological activity of novel antibacterial quinazolines","volume":"14","author":"Bedi","year":"2004","journal-title":"Bioorganic Med Chem Lett."},{"issue":"3","key":"10.1016\/j.bmcl.2022.128531_b0145","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/jm401204g","article-title":"Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(Benzimidazol-1-yl)-2,4-diaminoquinazolines","volume":"57","author":"Lam","year":"2014","journal-title":"J Med Chem."},{"issue":"17","key":"10.1016\/j.bmcl.2022.128531_b0150","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.bmcl.2013.06.048","article-title":"Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines","volume":"23","author":"Parhi","year":"2013","journal-title":"Bioorganic Med Chem Lett."},{"issue":"6","key":"10.1016\/j.bmcl.2022.128531_b0155","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00059-17","article-title":"Characterizing the antimicrobial activity of N2, N4-disubstituted quinazoline-2,4-diamines toward multidrug-resistant Acinetobacter baumannii","volume":"61","author":"Fleeman","year":"2017","journal-title":"Antimicrob Agents Chemother."},{"issue":"7","key":"10.1016\/j.bmcl.2022.128531_b0160","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1039\/C9MD00156E","article-title":"Anti-biofilm activity of quinazoline derivatives against Mycobacterium smegmatis","volume":"10","author":"Cox","year":"2019","journal-title":"MedChemComm."},{"key":"10.1016\/j.bmcl.2022.128531_b0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejmech.2015.03.014","article-title":"Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase","volume":"94","author":"Lu","year":"2015","journal-title":"Eur J Med Chem."},{"issue":"1","key":"10.1016\/j.bmcl.2022.128531_b0170","doi-asserted-by":"crossref","first-page":"e1008270","DOI":"10.1371\/journal.ppat.1008270","article-title":"New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis","volume":"16","author":"Lupien","year":"2020","journal-title":"PLoS Pathog."},{"issue":"24","key":"10.1016\/j.bmcl.2022.128531_b0175","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1016\/j.bmc.2014.10.007","article-title":"Synthesis and evaluation of the 2,4-diaminoquinazoline series as anti-tubercular agents","volume":"22","author":"Odingo","year":"2014","journal-title":"Bioorg Med Chem."},{"issue":"22","key":"10.1016\/j.bmcl.2022.128531_b0180","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1021\/jm9903500","article-title":"Structure\u2212activity relationships of novel 2-substituted quinazoline antibacterial agents","volume":"42","author":"Kung","year":"1999","journal-title":"J Med Chem."},{"issue":"1","key":"10.1016\/j.bmcl.2022.128531_b0185","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/jm00163a067","article-title":"Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolines","volume":"33","author":"Harris","year":"1990","journal-title":"J Med Chem."},{"issue":"5","key":"10.1016\/j.bmcl.2022.128531_b0190","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02637-18","article-title":"The quinazolinone allosteric inhibitor of PBP 2a synergizes with piperacillin and tazobactam against methicillin-resistant Staphylococcus aureus","volume":"63","author":"Janardhanan","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"issue":"7","key":"10.1016\/j.bmcl.2022.128531_b0195","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1021\/jm500039e","article-title":"Antibacterial activity of a Series of N2, N4-disubstituted quinazoline-2,4-diamines","volume":"57","author":"Van Horn","year":"2014","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2022.128531_b0200","doi-asserted-by":"crossref","first-page":"105422","DOI":"10.1016\/j.bioorg.2021.105422","article-title":"Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Optimization of the 2,4-substituents","volume":"117","author":"Aboushady","year":"2021","journal-title":"Bioorg Chem."},{"issue":"3","key":"10.1016\/j.bmcl.2022.128531_b0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/138945010790711996","article-title":"Halogen atoms in the modern medicinal chemistry: hints for the drug design","volume":"11","author":"Marcelo Zaldini","year":"2010","journal-title":"Curr Drug Targets"},{"issue":"21","key":"10.1016\/j.bmcl.2022.128531_b0210","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J Med Chem."},{"issue":"6","key":"10.1016\/j.bmcl.2022.128531_b0215","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/0957-4166(96)00198-X","article-title":"Studies on quinazolines. 6. Asymmetric synthesis of (S)-(+)- and (R)-(\u2212)-3-[[4-(2-methoxyphenyl)piperazin-1-yl]methyl]-5-methylthio-2,3-dihydroimidazo[1,2-c]quinazolines","volume":"7","author":"Alexander","year":"1996","journal-title":"Tetrahedron Asymmetry"},{"issue":"4","key":"10.1016\/j.bmcl.2022.128531_b0220","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1248\/cpb.39.900","article-title":"Studies on cardiotonic agents. VII. Potent cardiotonic Agent KF15232 with myofibrillar Ca2+ sensitizing effect","volume":"39","author":"Nomoto","year":"1991","journal-title":"Chem Pharm Bull."},{"issue":"35","key":"10.1016\/j.bmcl.2022.128531_b0225","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1039\/D1OB01315G","article-title":"Nucleophile\u2013nucleofuge duality of azide and arylthiolate groups in the synthesis of quinazoline and tetrazoloquinazoline derivatives","volume":"19","author":"Jeminejs","year":"2021","journal-title":"Org Biomol Chem."},{"issue":"1","key":"10.1016\/j.bmcl.2022.128531_b0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/088532829501000104","article-title":"A review of the effects of gamma radiation on pharmaceutical materials","volume":"10","author":"Jacobs","year":"1995","journal-title":"J Biomater Appl."},{"issue":"2","key":"10.1016\/j.bmcl.2022.128531_b0235","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.radphyschem.2004.02.006","article-title":"Radiostability of pharmaceuticals under different irradiation conditions","volume":"72","author":"Crucq","year":"2005","journal-title":"Radiat Phys Chem."},{"issue":"10","key":"10.1016\/j.bmcl.2022.128531_b0240","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.radphyschem.2010.04.014","article-title":"Study on gamma and electron beam sterilization of third generation cephalosporins cefdinir and cefixime in solid state","volume":"79","author":"Singh","year":"2010","journal-title":"Radiat Phys Chem."},{"key":"10.1016\/j.bmcl.2022.128531_b0245","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejbt.2016.11.009","article-title":"Radiolytic studies of cefozopran hydrochloride in the solid state","volume":"25","author":"Zalewski","year":"2017","journal-title":"Electron J Biotechnol."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22000075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22000075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:44:23Z","timestamp":1760773463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22000075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":49,"alternative-id":["S0960894X22000075"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128531","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Modification of the benzenoid part","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128531"}}